Michail Eleftheriou
Angel Investor
London, United Kingdom
Michail Eleftheriou is a seed investor in London focused on Software and Life Science. Michail Eleftheriou
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Michail Eleftheriou invests in
Stages Michail Eleftheriou invests in
Countries Michail Eleftheriou invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $150k–$900k
Investment Focus
Industry
- Software 1 (50%)
- Life Science 1 (50%)
- Biotechnology 1 (50%)
- Pharmaceutical 1 (50%)
- Internet of Things 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| iNovar Corporation has its origins in the team who were rated #1 by Gartner in 2012 for “Mobilizing Existing BI Content” and has created a new structure to attack this ‘hot’ market – estimated by Gartner to be worth approx. $2.5b in annual license fees.Initial discussions to secure rights to the earlier IP failed to materialise and a decisionwas made in March 2013 to completely re-develop, from first principles, an even more innovative solution called MyBI 2Go. MyBI 2Go Snap , a cloud-based system providing corporate access to internal dashboards and reports within hours was released on iTunes on October 21st, 2013 and the next release, MyBI 2Go Enterprise, which enables corporates to install the system on-premise is due for release in Q2 2014.With 350+ corporate NDAs to work with the team and initial clients signed since the release including the Metropolitan Police (UK), Orange (Switzerland) and Alghanim (Kuwait) and POC’s underway with Marks & Spencer (UK), M3 Medical (US), Deloitte (Mexico) and Al Futtaim (Dubai), we are seeking up to £1.25m in £500k tranches, offering preference convertible stock with a 10% coupon in exchange, to commence our US & International sales and marketing plans properly. | $150K / Seed / Sep 25, 2014 | ||
| Synthace is a digital experiment platform built for life science R&D teams to help them run more powerful experiments. It digitizes experiments from end to end: with minimal training, scientists can design and plan reproducible experiments, simulate them ahead of time, run them on their automation equipment, and automatically structure all oftheir experimental data and metadata in a single place. Controlled from a browser window and needing no code to operate, it makes experiments easier to run in the lab, increases the scientific value of experiments, and also makes it possible to run experiments that were previously thought impossible. | $900K / Seed / Apr 12, 2013 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Michail Eleftheriou invest in?
Michail Eleftheriou invests primarily in Software, Life Science and Biotechnology startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Michail Eleftheriou's check size?
Michail Eleftheriou typically joins rounds of $150k–$900k at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Michail Eleftheriou participates in.
How do I contact Michail Eleftheriou?
Public channels for Michail Eleftheriou include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Michail Eleftheriou last invest?
The most recent investment recorded for Michail Eleftheriou closed in Sep 2014. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
